As they are more stable and practical molecules to measure, apoB measurement and/or apoB/apoA-I ratio calculation should be probably introduced into the gamut of risk predictors for atherosclerotic disease in HD patients, provided that larger prospective studies confirm the preliminary results of the present study. The gene discussed is APOB; the disease is Huntington disease.